Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

EIHSX vs. PRHSX: which is better?

Bottom line

EIHSX vs PRHSX: the short answer

EIHSX (Eaton Vance Worldwide Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.

But PRHSX is far broader, holding 279 positions to 42 for EIHSX, so beyond the top names it adds exposure EIHSX doesn't have.

PRHSX is cheaper at 0.83% vs 0.93% — a difference of $10.00 a year per $10,000 invested.

Over five years, EIHSX returned +6.7% a year vs +4.2% for PRHSX (reporting dates differ).

Updated Nov 19, 2026

EIHSX vs PRHSX side by side

EIHSXPRHSX
TypeMutual fundMutual fund
Fund familyMorgan StanleyT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.93%0.83%
Annual cost per $10k$93$83
10-yr cost on $10k (prospectus)$1,175$1,025
Max front load0%—
12b-1 fee0%—
1-yr return+3.7%+17.7%
5-yr return (annualized)+6.7%+4.2%
10-yr return (annualized)+7.2%+9.1%
Best quarter—+23.5%
Worst quarter—−15.8%
Net assets (fund)$757.9M$11.9B
Number of holdings42279
Portfolio turnover3%62%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

12 of EIHSX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingEIHSXPRHSX
Eli Lilly & Co12.47%14.28%
AbbVie Inc6.46%5.10%
Johnson & Johnson6.45%6.63%
UnitedHealth Group Inc5.49%5.99%
Merck & Co Inc5.08%4.01%
Bristol-Myers Squibb Co4.25%2.11%
Vertex Pharmaceuticals Inc3.38%2.28%
Gilead Sciences Inc3.34%2.82%
Thermo Fisher Scientific Inc2.79%2.52%
Intuitive Surgical Inc2.72%1.87%
Stryker Corp2.21%1.78%
Abbott Laboratories1.65%1.89%

Source: SEC Form N-PORT

EIHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between EIHSX and PRHSX?
EIHSX (Eaton Vance Worldwide Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. But PRHSX is far broader, holding 279 positions to 42 for EIHSX, so beyond the top names it adds exposure EIHSX doesn't have.
Which is cheaper, EIHSX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both EIHSX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.